2026 Annual Meeting | S30 - Autoimmune Neurology: Clinical CNS Autoimmune and Inflammatory Disorders
Program Materials Program Evaluations
| Josep O. Dalmau, MD, PhD, FAAN | Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. |
| Barney J. Stern, MD, FAAN | Dr. Stern has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Foundation for Sarcoidosis Research. The institution of Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. Dr. Stern has received publishing royalties from a publication relating to health care. |
| Jeffrey A. Cohen, MD | Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion. |
| Orhun H. Kantarci, MD | Dr. Kantarci has nothing to disclose. |
| Marinos C. Dalakas, MD, FAAN | Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. |
| Francesc R. Graus, MD | Dr. Graus has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Graus has received intellectual property interests from a discovery or technology relating to health care. |
| Andrew McKeon, MD | The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care. |
| Sean J. Pittock, MD, FAAN | Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care. |
| Takahiro Iizuka, MD | The institution of Dr. Iizuka has received research support from EUROIMMUN Japan Co., Ltd. |
| Kazutoshi Nishiyama, MD, PhD | Kazutoshi Nishiyama, MD, PhD has nothing to disclose. |
| Aksel Siva, MD | Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants. |
| Patrice LaLive, MD | Dr. LaLive has nothing to disclose. |
| Carlos A. Pardo-Villamizar, MD | The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research . |
| Jerome Honnorat, MD, PhD | Jerome Honnorat, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LFB. The institution of Jerome Honnorat, MD, PhD has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for journal of neurology. |
| Michael Levy, MD, PhD, FAAN | Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health. |
| Maarten J. Titulaer, MD, PhD | The institution of Dr. Titulaer has received research support from Dutch Epilepsy Foundations (NEF 19-08). The institution of Dr. Titulaer has received research support from CSL Behring. The institution of Dr. Titulaer has received research support from UCB. The institution of Dr. Titulaer has received research support from Netherlands Organisation for Scientific Research (ZonMW, Memorabel initiative and E-RARE UltraAIE) . The institution of Dr. Titulaer has received research support from Horizon Therapeutics / Amgen. The institution of Dr. Titulaer has received research support from Dioraphte (charity). The institution of Dr. Titulaer has received research support from Guidepoint Global LLC. The institution of Dr. Titulaer has received research support from ArgenX. Dr. Titulaer has received intellectual property interests from a discovery or technology relating to health care. Dr. Titulaer has received publishing royalties from a publication relating to health care. |
| Akio Ikeda, MD | Dr. Ikeda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Japan. Dr. Ikeda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sumitomo pharms. The institution of Dr. Ikeda has received research support from sumitomo pharma. The institution of Dr. Ikeda has received research support from UCB Japan. The institution of Dr. Ikeda has received research support from Nihon Kohden. The institution of Dr. Ikeda has received research support from Eli Lilly. The institution of Dr. Ikeda has received research support from Richo. |
| Renaud A. Du Pasquier, MD, FAAN | Dr. Du Pasquier has nothing to disclose. |
| Eric Lancaster, MD, PhD | Dr. Lancaster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merck. Dr. Lancaster has received intellectual property interests from a discovery or technology relating to health care. Dr. Lancaster has received personal compensation in the range of $50,000-$99,999 for serving as a Expert and Witness with US Vaccine Injury Compensation Program. |
| Peter Sillevis Smitt, MD | The institution of Dr. Sillevis Smitt has received research support from Euroimmun. Dr. Sillevis Smitt has received intellectual property interests from a discovery or technology relating to health care. |
| Eoin P. Flanagan, MBBCh, FAAN | The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities. |
| Yolanda Blanco Morgado, MD | Dr. Blanco Morgado has nothing to disclose. |
| Ugur Uygunoglu | Ugur Uygunoglu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Turkey . The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec/Gen Pharma of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck-Serono of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanovel of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genveon of Turkey. |
| Mateus M. Simabukuro, MD | Dr. Simabukuro has nothing to disclose. |
| Juntaro Kaneko | Juntaro Kaneko has nothing to disclose. |
| Thais Armangue, MD | Dr. Armangue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Armangue has received research support from ISCIII(Spanish institute of health) -PI21/00316, Marato TV3, La Caixa Research Foundadion, Pablove Foundation (689368), Torrons Vicens Foundation (PFNR0144), 2021 Invest AEP. |
| Divyanshu Dubey, MD, FAAN | The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. |
| Shailee S. Shah, MD | Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Shah has received publishing royalties from a publication relating to health care. |
| Monique Anderson, MD, PhD | Dr. Anderson has nothing to disclose. |
| Masaaki Nakamura | Masaaki Nakamura has nothing to disclose. |
| Eiji Kitamura | Eiji Kitamura has nothing to disclose. |
| Sabahattin Saip | Sabahattin Saip has nothing to disclose. |
| Carsten Finke, MD | Carsten Finke, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myer Squibb. The institution of Carsten Finke, MD has received research support from Euroimmun. |
| Naomi Kanazawa | Naomi Kanazawa has nothing to disclose. |
| Rinze F Neuteboom | Rinze F Neuteboom has nothing to disclose. |
| Burcu Zeydan, MD | The institution of Dr. Zeydan has received research support from National Institutes of Health. |
| Anastasia Zekeridou, MD, PhD, FAAN | The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. |
| James V. Nguyen, MD, MEd | Dr. Nguyen has nothing to disclose. |
| Amy Kunchok, MBBS | Dr. Kunchok has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology:Open Access Journal . |
| Philippe-Antoine Bilodeau, MD | Dr. Bilodeau has or had stock in Roche. The institution of Dr. Bilodeau has received research support from Alexion Pharmaceuticals. The institution of Dr. Bilodeau has received research support from Department of Defense. Dr. Bilodeau has received research support from Canadian Institutes of Health Research. The institution of Dr. Bilodeau has received research support from Ann Theodore Foundation. Dr. Bilodeau has received research support from The MOG Project. |
| Agnes Van Sonderen | No disclosure on file |
| Romana Hoeftberger | Romana Hoeftberger has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology: Neuroimmunology and Neuroinflammation. Romana Hoeftberger has received personal compensation in the range of $500-$4,999 for serving as a speaker with BMS and UCB Biopharma. |
| Melih Tutuncu, MD | Dr. Tutuncu has nothing to disclose. |
| Anna Bastiaansen | Anna Bastiaansen has nothing to disclose. |
| Popianna Tsiortou | Popianna Tsiortou has nothing to disclose. |
| Alise K. Carlson, MD | Dr. Carlson has received research support from Biogen (fellowship grant 16696-P-FEL). |
| Benjamin Clarkson | Benjamin Clarkson has received research support from Adimune. Benjamin Clarkson has received research support from Dominium Foundation. |
| Mar Guasp, MD | Dr. Guasp has nothing to disclose. |
| John R. Mills, MD, PhD | The institution of Dr. Mills has received research support from Werfen Diagnostics. Dr. Mills has received intellectual property interests from a discovery or technology relating to health care. |
| Takahisa Mikami, MD | Dr. Mikami has nothing to disclose. |
| David Acero-Garces, MD | Dr. Acero-Garces has nothing to disclose. |
| Binxia Yang | Binxia Yang has nothing to disclose. |
| Yahel Segal, MD | Dr. Segal has nothing to disclose. |
| Juliette Brenner, MD | Ms. Brenner has nothing to disclose. |
| Clare M. Lambert, MD | Dr. Lambert has nothing to disclose. |
| Frank Leypoldt, MD | Frank Leypoldt, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Frank Leypoldt, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Frank Leypoldt, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Frank Leypoldt, MD has received research support from German Ministry of Research BMBF. |
| Joao Vitor Mahler, MD | Dr. Mahler has received research support from The Sumaira Foundation. |
| Tsubasa Takizawa, MD, PhD | Prof. Takizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Prof. Takizawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Otsuka. Prof. Takizawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Prof. Takizawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teijin. Prof. Takizawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Prof. Takizawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Daiichi Sankyo. Prof. Takizawa has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Otsuka. Prof. Takizawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. Prof. Takizawa has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Daiichi Sankyo. Prof. Takizawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Prof. Takizawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sawai. Prof. Takizawa has received research support from Eli Lilly. Prof. Takizawa has received research support from JSPS KAKENHI. Prof. Takizawa has received research support from Pfizer. |
| Yvette Crijnen | Yvette Crijnen has nothing to disclose. |
| Juna De Vries | Juna De Vries has nothing to disclose. |
| Masaki Iizuka | Masaki Iizuka has nothing to disclose. |
| Stefan Macher | Stefan Macher has nothing to disclose. |
| Michael Gilligan, MBBS | Dr. Gilligan has nothing to disclose. |
| Saira Afzal, MD | Dr. Afzal has nothing to disclose. |
| Tomomi Iwami | Tomomi Iwami has nothing to disclose. |
| Jeroen Kerstens, MD | Mr. Kerstens has received research support from European Joint Programme on Rare Diseases. The institution of Mr. Kerstens has received research support from Erasmus Trust Fund. |
| Sharon Veenbergen | Sharon Veenbergen has nothing to disclose. |
| Pei Shang, MD, PhD | Dr. Shang has nothing to disclose. |
| Robin W. van Steenhoven, MD | Dr. van Steenhoven has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. van Steenhoven has received research support from Autoimmune Encephalitis Alliance . The institution of Dr. van Steenhoven has received research support from Dutch Alzheimer's foundation. The institution of Dr. van Steenhoven has received research support from ItsME Foundation. The institution of Dr. van Steenhoven has received research support from Erasmus University Medical Center. |
| Gemma Olivé, MD | Dr. Olivé has nothing to disclose. |
| Friederike A. Arlt, MD | Dr. Arlt has nothing to disclose. |
| Jonas H. Yeung, MD, MB, ChB, FRCP | Dr. Yeung has nothing to disclose. |
| Kurt-Wolfram Suhs | Kurt-Wolfram Suhs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Kurt-Wolfram Suhs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Kurt-Wolfram Suhs has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Kurt-Wolfram Suhs has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Kurt-Wolfram Suhs has received research support from Bristol Myers Squibb. |
| Ariel Heller, MD | Dr. Heller has nothing to disclose. |
| Munther Queisi, MD | Dr. Queisi has nothing to disclose. |
| Natalia Drosu | Ms. Drosu has nothing to disclose. |
| Mamoru Shibata | Mamoru Shibata has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Japanese Headache Society. Mamoru Shibata has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Japanese Headache Society. Mamoru Shibata has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Japanese Society of Neurology. The institution of Mamoru Shibata has received research support from Otsuka Pharmaceutical Co. Ltd.. |
| Hitomi Nakagawa | Ms. Nakagawa has nothing to disclose. |
| Laura Marmolejo Alcaide | Miss Marmolejo Alcaide has nothing to disclose. |
| Jesus Planaguma | Dr. Planaguma has nothing to disclose. |
| Esther Aguilar, Bachelor of science | Mrs. Aguilar has nothing to disclose. |
| Hiroto Nakagawa, PhD | Dr. Nakagawa has nothing to disclose. |
| Yoshikane Izawa, MD, PhD | The institution of Dr. Izawa has received research support from Ministry of Education, Culture, Sports, Science and Technology (JAPAN). |
| Takayasu Mishima, MD | Prof. Mishima has nothing to disclose. |
| Sho Shimohama | The institution of Dr. Shimohama has received research support from Grant-in-Aid for JSPS Fellows. |
| Giovanni Di Liberto, MD, PhD | Dr. Di Liberto has nothing to disclose. |
| Katharina Wurdack, MD | Ms. Wurdack has nothing to disclose. |
| Klaus Peter Wandinger, MD | Prof. Wandinger has nothing to disclose. |
| Kang Wang, MD | Dr. Wang has nothing to disclose. |
| Gülen Hatemi, MD | Prof. Hatemi has nothing to disclose. |
| osman kizilkilic, MD | Prof. kizilkilic has nothing to disclose. |
| Maria-Jesus Martinez-Gonzalez, MD | Mrs. Martinez-Gonzalez has nothing to disclose. |
| Eri Fukao, MD | Dr. FUKAO has nothing to disclose. |
| serdal ugurlu | Prof. ugurlu has nothing to disclose. |
| Emire Seyahi, MD | Dr. Seyahi has nothing to disclose. |
| María Isabella Bonilla-Arbelaez | Miss Bonilla has nothing to disclose. |
| Teresa Casadevall | No disclosure on file |
| Christopher Hogge, MD | Dr. Hogge has nothing to disclose. |
| Agnita J. Boon, MD, PhD | The institution of Dr. Boon has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. The institution of Dr. Boon has received research support from Erasmus Trust Fonds. |
| Marleen van Coevorden, MD | Dr. van Coevorden has nothing to disclose. |
| Shintaro Saegusa, MD | Dr. Saegusa has nothing to disclose. |
| Marienke de Bruijn, MD, PhD | Dr. de Bruijn has nothing to disclose. |
| Juan P. Fernandez, MD | Dr. Fernandez has nothing to disclose. |
| MAYA TOJIMA, MD, PhD | Dr. TOJIMA has nothing to disclose. |
| Shuichiro Neshige, MD, PhD | Mr. Neshige has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Japan. |
| Diana Anissian, MD | Dr. Anissian has nothing to disclose. |
| Konstantinos Barsakis | Mr. Barsakis has nothing to disclose. |
| Nursena Erener, MD | Dr. Erener has nothing to disclose. |
| naci kocer, MD | Prof. kocer has received personal compensation in the range of $0-$499 for serving as a Consultant for MICROVENTION. Prof. kocer has stock in BENDIT. |
| Marie R. Vermeiren, MD | Ms. Vermeiren has nothing to disclose. |
| guillermo muñoz | Mr. muñoz has nothing to disclose. |
| Roger Borràs, BSc | Mr. Borràs has nothing to disclose. |
| Sandy A. Mazzoni, DO | Dr. Mazzoni has nothing to disclose. |
| Timothy E. Bael, MD | Dr. Bael has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gale Gael and Hunt. |
| Faiz Anwer, MD | Dr. Anwer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Anwer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Caribou biosciences. Dr. Anwer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GI Innovation . Dr. Anwer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Poseida Therapeutics. |
| Shahzad Raza, MD | Dr. Raza has received personal compensation for serving as an employee of DAVA oncology . Dr. Raza has received personal compensation for serving as an employee of Med outlook. Dr. Raza has received personal compensation for serving as an employee of Kaplan . Dr. Raza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharma . Dr. Raza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nexcella . Dr. Raza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena . |
| Jack Khouri, MD | Dr. Khouri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for J&J. Dr. Khouri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Legend biotech. Dr. Khouri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kite. Dr. Khouri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. |
| Yesim Ozguler, MD | Dr. Ozguler has nothing to disclose. |
| Christy J. Samaras, DO | Dr. Samaras has nothing to disclose. |
| civan b. islak, MD | Dr. islak has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for microvention. Dr. islak has stock in bendit inc. Dr. islak has stock in neuravention. |
| Sinem Nihal Esatoglu | No disclosure on file |
| Melike Melikoglu | No disclosure on file |